(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

TRATAMENTO DE NEUROFIBROMAS CUTÂNEOS COM MIRDAMETINIB

Em AnáliseInvention PatentPCT · US2023064572

Application data

Number

112024019022

Type

Invention Patent

Filing

03/16/2023

Publication

12/24/2024

PCT

US2023064572

Progress at the INPI

  1. Filing03/16/23
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 03/16/2023. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 12/24/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

SPRINGWORKS THERAPEUTICS, INC.

US

See this company's full portfolio

Inventors

A. L. (pessoa física)

US

U. I. (pessoa física)

US

Technical data

Priority claims

US

63/321,036 · 03/17/2022

US

63/321,046 · 03/17/2022

Abstract

TRATAMENTO DE NEUROFIBROMAS CUTÂNEOS COM MIRDAMETINIB. A presente invenção refere-se a métodos para tratar neurofibromas cutâneos (cNF) compreendendo administrar a um paciente em necessidade do mesmo mirdametinib ou um sal farmaceuticamente aceitável do mesmo.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

12/24/2024

RPI 2816

Alteração de dados cadastrais

#1.1

09/24/2024

RPI 2803

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.